Jansen's Info

Signs & Symptoms

School Accomodations

Presenting Jansen's at School

About

Founder's Story

Medical & Scientific Advisory Board

Our Community

Jansen's' Stories

Events

Treatment Breakthroughs

First-Ever Clinical Trial

Natural History Study

Publications

Craniofacial Features

Vision=Related Challenges

A mouse-model for Jansen's

An inverse agonist ligand for Jansen's

Osteocyte Dysfunction in Jansen’s Disease

Zfp521 Ablation in Jansen’s Mouse Model

Variability in Jansen’s Disease

Jansen's Info

Signs & Symptoms

School Accomodations

Presenting Jansen's at School

About

Founder's Story

Medical & Scientific Advisory Board

Our Community

Jansen's' Stories

Events

Treatment Breakthroughs

First-Ever Clinical Trial

Natural History Study

Publications

Craniofacial Features

Vision=Related Challenges

A mouse-model for Jansen's

An inverse agonist ligand for Jansen's

Osteocyte Dysfunction in Jansen’s Disease

Zfp521 Ablation in Jansen’s Mouse Model

Variability in Jansen’s Disease

Medical & Scientific Advisory Board
Dr. Harald Jueppner
Dr. Thomas J. Gardella
Dr. Isidro B. Salusky
Dr. William G. Mackenzie
Dr. Michael B. Bober
Colleen P. Ditro, NP
Barbara Gales, RN, BSN
Dr. Minnie Vishwanath

Colleen P. Ditro, NP

Nemours/Alfred I. duPont Hospital for Children

1600 Rockland Road

Wilmington, DE

Scientific Advisory Board

The Jansen's Foundation, PO BOX 115, Elkhorn, NE, 68022, US402-457-9886info@thejansensfoundation.org

THE JANSEN'S FOUNDATION IS A REGISTERED 501(C)(3) CHARITY. © 2017
All Rights Reserved

The Jansen's Foundation Newsletter

Subscribe

Sign up with your email address to receive news and updates.

Email Address

We respect your privacy. We will not give out your email.

Thank you!